This is a randomized study to treat subjects diagnosed with pulmonary embolism with inhaled
nitric oxide or placebo (oxygen).
Phase:
Phase 2
Details
Lead Sponsor:
Indiana University School of Medicine
Collaborators:
Mallinckrodt National Heart, Lung, and Blood Institute (NHLBI) National Institutes of Health (NIH) University of Mississippi Medical Center University of Texas, Southwestern Medical Center at Dallas